<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tewalt EF</submitter><funding>NIAID NIH HHS</funding><funding>NCI NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>4772-82</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3520619</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>120(24)</volume><pubmed_abstract>Lymphatic endothelial cells (LECs) induce peripheral tolerance by direct presentation to CD8 T cells (T(CD8)). We demonstrate that LECs mediate deletion only via programmed cell death-1 (PD-1) ligand 1, despite expressing ligands for the CD160, B- and T-lymphocyte attenuator, and lymphocyte activation gene-3 inhibitory pathways. LECs induce activation and proliferation of T(CD8), but lack of costimulation through 4-1BB leads to rapid high-level expression of PD-1, which in turn inhibits up-regulation of the high-affinity IL-2 receptor that is necessary for T(CD8) survival. Rescue of tyrosinase-specific T(CD8) by interference with PD-1 or provision of costimulation results in autoimmune vitiligo, demonstrating that LECs are significant, albeit suboptimal, antigen-presenting cells. Because LECs express numerous peripheral tissue antigens, lack of costimulation coupled to rapid high-level up-regulation of inhibitory receptors may be generally important in systemic peripheral tolerance.</pubmed_abstract><journal>Blood</journal><pubmed_title>Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells.</pubmed_title><pmcid>PMC3520619</pmcid><funding_grant_id>T32 AI007496</funding_grant_id><funding_grant_id>T32 GM007267</funding_grant_id><funding_grant_id>AI07496</funding_grant_id><funding_grant_id>CA44579</funding_grant_id><funding_grant_id>GM007267</funding_grant_id><funding_grant_id>R01 GM100776</funding_grant_id><funding_grant_id>R01 AI068836</funding_grant_id><funding_grant_id>AI068836</funding_grant_id><funding_grant_id>P30 CA044579</funding_grant_id><funding_grant_id>R01 CA109339</funding_grant_id><pubmed_authors>Tung KS</pubmed_authors><pubmed_authors>Tewalt EF</pubmed_authors><pubmed_authors>Cohen JN</pubmed_authors><pubmed_authors>Rouhani SJ</pubmed_authors><pubmed_authors>Qiao H</pubmed_authors><pubmed_authors>Vella AT</pubmed_authors><pubmed_authors>Bender TP</pubmed_authors><pubmed_authors>Chen L</pubmed_authors><pubmed_authors>Guidi CJ</pubmed_authors><pubmed_authors>Conaway MR</pubmed_authors><pubmed_authors>Engelhard VH</pubmed_authors><pubmed_authors>Adler AJ</pubmed_authors><pubmed_authors>Fahl SP</pubmed_authors></additional><is_claimable>false</is_claimable><name>Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells.</name><description>Lymphatic endothelial cells (LECs) induce peripheral tolerance by direct presentation to CD8 T cells (T(CD8)). We demonstrate that LECs mediate deletion only via programmed cell death-1 (PD-1) ligand 1, despite expressing ligands for the CD160, B- and T-lymphocyte attenuator, and lymphocyte activation gene-3 inhibitory pathways. LECs induce activation and proliferation of T(CD8), but lack of costimulation through 4-1BB leads to rapid high-level expression of PD-1, which in turn inhibits up-regulation of the high-affinity IL-2 receptor that is necessary for T(CD8) survival. Rescue of tyrosinase-specific T(CD8) by interference with PD-1 or provision of costimulation results in autoimmune vitiligo, demonstrating that LECs are significant, albeit suboptimal, antigen-presenting cells. Because LECs express numerous peripheral tissue antigens, lack of costimulation coupled to rapid high-level up-regulation of inhibitory receptors may be generally important in systemic peripheral tolerance.</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012 Dec</publication><modification>2021-02-27T08:23:01Z</modification><creation>2019-03-27T01:01:43Z</creation></dates><accession>S-EPMC3520619</accession><cross_references><pubmed>22993390</pubmed><doi>10.1182/blood-2012-04-427013</doi></cross_references></HashMap>